Track Global Health Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Global Health Limited MEDANTA.NS · Stock Open Global Health Limited in new tab

1280.20 INR
P/E
61.91
EPS
20.68
Yield
0.08%
Safety Score
17
P/B
8.68
ROE
15.03
Beta
0.16
Target Price
1599.05 INR
Loading chart...
Key Metrics
Earnings dateNov. 6, 2026
P/E61.91
EPS20.68
Book Value147.47
Price to Book8.68
Debt/Equity29.87
% Insiders66.385%
Growth
Revenue Growth0.27%
Earnings Growth0.00%
Estimates
Forward P/E38.11
Forward EPS33.60
Target Mean Price1599.05
Dividend
Dividend Yield0.08%
Annual dividends1.00 INR
Ex-Div. DateAug. 14, 2026

DCF valuation

Model fair value for Global Health Limited (MEDANTA.NS)
Result
Sign in to run the valuation for MEDANTA.NS.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
19 analysts · consensus Buy · mean target 1599.05 INR (low 1410.00, high 1799.00) · as of 13 Oct 2026
Low 1410.00
Mean 1599.05
High 1799.00
Price 1280.20
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Global Health Limited Logo Global Health Limited Analysis (MEDANTA.NS)

Is Global Health Limited a good investment? Global Health Limited (MEDANTA.NS) is currently trading at 1280.20 INR. Market analysts have a consensus price target of 1599.05 INR. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 61.91. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Global Health Limited is expected to release its next earnings report on Nov. 6, 2026. The market consensus estimate for Forward EPS is 33.60.

For income investors, Global Health Limited pays a dividend yield of 0.08%.

Investor FAQ

Does Global Health Limited pay a dividend?

Yes, it pays an annual dividend of 1.00 INR (0.08% yield).

What asset class is Global Health Limited?

Global Health Limited is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Nov. 6, 2026. The company currently has a trailing EPS of 20.68.

Company Profile

Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, lab and pathology, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinions, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup services. In addition, the company is involved in trading pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.

Trades
Dividend Yield
0.08%
Annual Dividends
1.00INR
Next Ex. Div Date
Aug. 14, 2026
Dividend History paid per year (INR)
Historical Dividends
Year Total Dividends
▸2027
0.50 INR
Aug. 16, 2027 (estimated) 0.5000
▸2026
1.00 INR
Oct. 19, 2026 (estimated) 0.5000
Aug. 14, 2026 0.5000
▸2025
0.50 INR
Oct. 19, 2025 0.5000
Upcoming Dividends
Name Payment Date Status Amount
Global Health Limited Aug 14, 2026 0.5 INR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion